Retifanlimab
Modify Date: 2024-04-06 12:25:58
Retifanlimab structure
|
Common Name | Retifanlimab | ||
|---|---|---|---|---|
| CAS Number | 2079108-44-2 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RetifanlimabRetifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb). Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA)[1]. |
| Name | Retifanlimab |
|---|
| Description | Retifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb). Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA)[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |